
Methylcobalamin (1500mcg) + Pregabalin (75mg) + Nortriptyline (10mg)
Active composition
+2 more active ingredients
Methylcobalamin acts as a cofactor in the synthesis of methionine from homocysteine, promoting nerve health and red blood cell formation.
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Nortriptyline inhibits the reuptake of norepinephrine and serotonin, increasing their levels in the synaptic cleft and enhancing mood.
Medical applications
Gudnerv-NT Tablet SR is a sustained-release formulation combining Pregabalin 75mg, Nortriptyline 10mg, and Methylcobalamin 1500mcg, designed for the management of neuropathic pain and associated conditions. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, acts by modulating calcium channels to reduce neurotransmitter release, thereby alleviating neuropathic pain and seizures. Nortriptyline, a tricyclic antidepressant, enhances noradrenergic and serotonergic neurotransmission, contributing to its analgesic and mood-stabilizing effects, particularly beneficial in chronic neuropathic pain syndromes. Methylcobalamin, an active form of vitamin B12, supports nerve regeneration and repair by promoting myelin sheath synthesis and neuronal function. The combination therapy targets multiple pathways involved in neuropathic pain, providing symptomatic relief and improving nerve health. Gudnerv-NT Tablet SR is indicated for diabetic neuropathy, postherpetic neuralgia, peripheral neuropathy, and other neuropathic pain disorders. It should be used under medical supervision, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include dizziness, somnolence, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with renal impairment, cardiac conditions, or those on concomitant central nervous system depressants. Regular monitoring is recommended to optimize therapeutic outcomes and minimize side effects.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Gudnerv-NT Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Gudnerv-NT Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Gudnerv-NT Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Gudnerv-NT Tablet SR may be needed. Please consult your doctor.
Exercise Caution
Gudnerv-NT Tablet SR may cause side effects which could affect your ability to drive. As Gudnerv-NT Tablet SR may affect your alertness which may affect your ability to drive.
Consult Doctor
Gudnerv-NT Tablet SR is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Gudnerv-NT Tablet SR may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Gudnerv-NT Tablet SR

Pregabalin (75mg) + Nortriptyline (10mg) + Methylcobalamin (1500mcg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Methylcobalamin acts as a cofactor in the synthesis of methionine from homocysteine, promoting nerve health and red blood cell formation.
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Nortriptyline inhibits the reuptake of norepinephrine and serotonin, increasing their levels in the synaptic cleft and enhancing mood.
Medical applications
Gudnerv-NT Tablet SR is a sustained-release formulation combining Pregabalin 75mg, Nortriptyline 10mg, and Methylcobalamin 1500mcg, designed for the management of neuropathic pain and associated conditions. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, acts by modulating calcium channels to reduce neurotransmitter release, thereby alleviating neuropathic pain and seizures. Nortriptyline, a tricyclic antidepressant, enhances noradrenergic and serotonergic neurotransmission, contributing to its analgesic and mood-stabilizing effects, particularly beneficial in chronic neuropathic pain syndromes. Methylcobalamin, an active form of vitamin B12, supports nerve regeneration and repair by promoting myelin sheath synthesis and neuronal function. The combination therapy targets multiple pathways involved in neuropathic pain, providing symptomatic relief and improving nerve health. Gudnerv-NT Tablet SR is indicated for diabetic neuropathy, postherpetic neuralgia, peripheral neuropathy, and other neuropathic pain disorders. It should be used under medical supervision, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include dizziness, somnolence, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with renal impairment, cardiac conditions, or those on concomitant central nervous system depressants. Regular monitoring is recommended to optimize therapeutic outcomes and minimize side effects.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Gudnerv-NT Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Gudnerv-NT Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Gudnerv-NT Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Gudnerv-NT Tablet SR may be needed. Please consult your doctor.
Exercise Caution
Gudnerv-NT Tablet SR may cause side effects which could affect your ability to drive. As Gudnerv-NT Tablet SR may affect your alertness which may affect your ability to drive.
Consult Doctor
Gudnerv-NT Tablet SR is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Gudnerv-NT Tablet SR may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Gudnerv-NT Tablet SR















